IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom +7.4% ·
netto nieuwe posities -6.2%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +2 | 148.59M | $11.08B | +6 | −3 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | — |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | — |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | — | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | — | −1 |
| Q2 2024 | 17 | — | 24.68M | $1.18B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 11.47M | +46.5% | $400.83M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 8.67M | -0.7% | $303.18M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (passief) | 5.43M | — | $189.71M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (passief) | 5.43M | — | $189.71M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passief) | 5.43M | — | $189.71M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 3.83M | -9.1% | $133.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 3.83M | -9.1% | $133.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 3.25M | -6.0% | $113.58M | 7.7% | ▼ Trim | 3 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 2.69M | +0.7% | $93.98M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 2.69M | +0.7% | $93.98M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 2.17M | +439.9% | $75.72M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 2.17M | +439.9% | $75.72M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 21 | Norges Bank ✦ (passief) | 1.71M | -15.4% | $59.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | ARK Investment Management ✦ | 1.03M | -25.9% | $35.84M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 921.44K | +0.3% | $32.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 24 | Marshall Wace ✦ | 812.31K | -57.7% | $28.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 812.31K | -57.7% | $28.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 812.31K | -57.7% | $28.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 27 | Millennium Management ✦ | 774.22K | +79.8% | $27.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 275.00K | -45.0% | $9.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Renaissance Technologies ✦ | 205.51K | +7.9% | $7.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 23.12K | -84.1% | $808,380 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 23.12K | -84.1% | $808,380 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 32 | Gotham Asset Management ✦ | 6.26K | 0.0% | $218,850 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Baillie Gifford | $1.59M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 490 houders, 170.17M aandelen, $11.94B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.